landiolol has been researched along with Coronary Artery Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Fushimi, K; Ikumi, S; Iwasaki, Y; Kaiho, Y; Nakajima, M; Ohbe, H; Sasabuchi, Y; Yamauchi, M; Yasunaga, H | 1 |
| Ishigami, T; Ishikawa, T; Iwata, K; Kimura, K; Kiyokuni, M; Komura, N; Konishi, M; Nakayama, N; Saigusa, Y; Sugano, T; Tamura, K; Yamanaka, T | 1 |
| Ishii, H; Isobe, S; Kato, M; Kobayashi, M; Meno, C; Mimura, T; Murohara, T; Sato, K; Sugiura, K | 2 |
| Omata, S; Sato, Y; Takase, S; Wakamatsu, H; Watanabe, T; Yokoyama, H | 1 |
| Bessho, R; Fujii, M; Ochi, M; Shimizu, K; Takeda, S; Terajima, K | 1 |
| Goto, K; Miyakawa, H; Miyamoto, S; Noguchi, T; Shingu, C | 1 |
5 trial(s) available for landiolol and Coronary Artery Disease
| Article | Year |
|---|---|
Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.
Topics: Adiponectin; Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Angina, Stable; Biomarkers; Coronary Artery Disease; Female; Humans; Japan; Male; Middle Aged; Molecular Weight; Morpholines; Percutaneous Coronary Intervention; Prospective Studies; Time Factors; Treatment Outcome; Urea | 2020 |
Use of landiolol hydrochloride, a new beta-blocker, in coronary computed tomography angiography.
Topics: Adrenergic beta-Antagonists; Aged; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Morpholines; Tomography, X-Ray Computed; Urea | 2010 |
Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: initial experience.
Topics: Aged; Anti-Arrhythmia Agents; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Tomography, X-Ray Computed; Urea | 2008 |
Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Injections, Intravenous; Male; Morpholines; Postoperative Care; Postoperative Complications; Prospective Studies; Treatment Outcome; Urea | 2012 |
The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Catheterization, Swan-Ganz; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Echocardiography, Transesophageal; Female; Heart Rate; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Stroke Volume; Thermodilution; Urea; Ventricular Function, Left | 2007 |
2 other study(ies) available for landiolol and Coronary Artery Disease
| Article | Year |
|---|---|
Association Between Intraoperative Landiolol Use and In-Hospital Mortality After Coronary Artery Bypass Grafting: A Nationwide Observational Study in Japan.
Topics: Coronary Artery Bypass; Coronary Artery Disease; Hospital Mortality; Humans; Japan; Retrospective Studies; Treatment Outcome | 2023 |
Landiolol reduces coronary artery motion in an open-chest porcine model: implications for off-pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Female; Imaging, Three-Dimensional; Infusions, Intravenous; Morpholines; Myocardial Contraction; Swine; Thoracotomy; Urea; Vasodilation | 2012 |